Data is not available at this time.
Sila Realty Trust, Inc. operates as a real estate investment trust (REIT) specializing in healthcare-related properties, primarily medical office buildings and outpatient facilities. The company generates revenue through long-term net leases, ensuring stable cash flows with built-in rent escalations. Its portfolio is strategically concentrated in high-growth markets, catering to the increasing demand for outpatient healthcare services due to demographic shifts and cost-efficient care models. Sila’s focus on mission-critical assets positions it as a resilient player in the healthcare real estate sector, benefiting from the non-discretionary nature of medical services. The REIT’s disciplined acquisition strategy targets properties with strong tenant covenants, often affiliated with leading healthcare systems, enhancing lease durability. By maintaining a diversified tenant base and prioritizing locations with favorable demographic trends, Sila mitigates concentration risks while capitalizing on the secular growth of outpatient care. Its market position is further strengthened by a conservative leverage profile and a commitment to accretive investments, aligning with long-term shareholder value creation.
Sila reported revenue of $186.9 million for the period, with net income of $42.7 million, translating to a diluted EPS of $0.76. Operating cash flow stood at $132.8 million, reflecting strong cash generation from its lease-heavy business model. Capital expenditures were modest at -$3.0 million, indicating efficient property maintenance and low redevelopment costs, typical for a net-lease REIT.
The company’s earnings power is underscored by its high-margin net lease structure, which minimizes variable costs. With operating cash flow significantly exceeding net income, Sila demonstrates robust capital efficiency, reinvesting selectively to maintain portfolio quality. Its focus on healthcare assets provides predictable cash flows, supporting consistent earnings growth and dividend sustainability.
Sila maintains a balanced financial position, with $39.8 million in cash and equivalents against total debt of $563.4 million. The debt level appears manageable given the stable cash flows from its leased properties. The REIT’s leverage is typical for the sector, and its net lease model reduces operational risks, contributing to financial stability.
Growth is driven by strategic acquisitions in outpatient healthcare real estate, supported by demographic tailwinds. Sila’s dividend of $1.60 per share reflects a payout ratio aligned with industry norms, emphasizing income stability for investors. The company’s focus on high-quality assets suggests potential for steady dividend growth alongside portfolio expansion.
The market likely values Sila based on its yield and growth prospects, with the dividend serving as a key benchmark. Trading multiples may reflect the premium for healthcare-focused REITs, given their defensive characteristics. Investor expectations hinge on the company’s ability to execute accretive acquisitions while maintaining lease stability.
Sila’s strategic advantages include its niche focus on healthcare real estate, long-term tenant relationships, and disciplined capital allocation. The outlook remains positive, supported by secular demand for outpatient facilities and the REIT’s conservative financial approach. Risks include interest rate sensitivity and tenant concentration, though these are mitigated by its lease structure and sector tailwinds.
Company filings (CIK: 0001567925), reported financials for FY ending 2024-12-31
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |